Biodesix INC Form 4 insider transactions

Chris Vazquez, Chief Accounting Officer of Biodesix Inc., acquired 14,280 stock options on February 21, 2024, as part of the company's 2023 Bonus-to-Options Program.

Gary Anthony Pestano, Chief Development Officer of Biodesix Inc., acquired 3,690 stock options on February 21, 2024, as part of the company's Bonus-to-Options Program.

Kieran O'Kane, Chief Commercial Officer of Bio-Rad Laboratories, acquired 35,307 stock options on February 21, 2024, as part of the company's Bonus-to-Options Program.

Biodesix CEO Scott Hutton acquired 180,926 stock options on February 21, 2024, as part of the company's 2023 Bonus-to-Options Program.

Robin Harper Cowie, CFO, Sec'y & Treasurer of BIODESIX INC, acquired 62,358 stock options on February 21, 2024, as part of the company's 2023 Bonus-to-Options Program.